Patents Examined by Teresa E Strzelecka
-
Patent number: 11835502Abstract: The analysis method for extracellular vesicles, according to the present invention, uses the size-specific separation ability of size exclusion chromatography and the properties of a probe that specifically binds with extracellular vesicles, and by using same is capable of the rapid and easy analysis of the quantity of extracellular vesicles included in a sample, analysis of the physicochemical properties of the extracellular vesicles, analysis of the kind and quantity of the components included in the extracellular vesicles, and analysis of the binding properties or affinity of the probe with respect to the components of the extracellular vesicles.Type: GrantFiled: September 27, 2018Date of Patent: December 5, 2023Assignee: ROSETTA EXOSOMEInventors: Yong Song Gho, Chang Jin Lee, Hyun Taek Park
-
Patent number: 11834711Abstract: The disclosure provides methods, compositions, systems, and kits for the concurrent detection and analysis of different structural and chemical forms of nucleic acids in a sample.Type: GrantFiled: September 24, 2021Date of Patent: December 5, 2023Assignee: Karius, Inc.Inventors: Timothy A Blauwkamp, Rene Sit, Igor D. Vilfan
-
Patent number: 11834709Abstract: A method and system for normalizing a polymerase chain reaction (PCR) amplification process for a plurality of samples containing DNA. Cycle data for performing the PCR amplification process is identified for the plurality of samples. The cycle data includes a corresponding cycle count for each sample of the plurality of samples. The plurality of samples is sorted into a plurality of bins based on the cycle data such that cycle count variation between bins of the plurality of bins is reduced. A bin cycle count is assigned to each bin of the plurality of bins. The bin cycle count is unique to each bin of the plurality of bins. Identification information is generated for the bins. An output for performing a PCR amplification of the plurality of samples is generated using the bins and the bin cycle count for each bin of the plurality of bins.Type: GrantFiled: October 14, 2021Date of Patent: December 5, 2023Assignee: Genentech, Inc.Inventors: Christian N. Cunningham, Kenneth Karl Hallenbeck
-
Patent number: 11834664Abstract: This disclosure describes methods and compositions for protein and peptide sequencing.Type: GrantFiled: September 11, 2020Date of Patent: December 5, 2023Assignee: Google LLCInventors: Annalisa Marie Pawlosky, Zachary Cutts, Shirley Jing Shao, Michelle Therese Hoerner Dimon, Marc Berndl, Alexander Julian Tran, Diana Terri Wu
-
Patent number: 11827925Abstract: An embodiment relates to system comprising: (i) a reaction mixture comprises: a) a target nucleic acid molecule; b) a forward primer complementary to a strand of the target nucleic acid molecule, the forward primer comprises a first molecular moiety at a 3? end, wherein the first molecular moiety is non-complementary to the strand of the target nucleic acid molecule; c) a reverse primer complementary to a complementary sequence of the strand of the target nucleic acid molecule, the reverse primer comprises a second molecular moiety at a 3? end, wherein the second molecular moiety is non-complementary to the complementary sequence of the strand of the target nucleic acid molecule; d) a polymerase with 3?-5? exonuclease activity; and (ii a device suitable of detecting an amplification products.Type: GrantFiled: December 31, 2020Date of Patent: November 28, 2023Assignee: AMPLIWISE INC.Inventors: Kai Wu, Mindy Su, Xing Su
-
Patent number: 11827933Abstract: Provided are an adaptor element in a bubble shape, a method of constructing a sequencing library with such an adapter element. The adaptor element is a hybrid formed with a long-chain nucleic acid A and a short-chain nucleic acid B. The hybrid is in the bubble shape with paired regions at two terminals and a non-paired region in the middle.Type: GrantFiled: February 10, 2021Date of Patent: November 28, 2023Assignee: MGI TECH CO., LTD.Inventors: Yuan Jiang, Xia Zhao, Qiaoling Li, Shengmao Liu, Bo Wang, Li Chen, Wenwei Zhang, Hui Jiang, Radoje Drmanac
-
Patent number: 11827945Abstract: The present invention provides a multiplex PCR detection kit of Listeria monocytogenes serotype 4h. The kit includes a gene Imo1210 detection primer and a gene xysn_1693 detection primer. The present invention establishes a multiplex PCR method for rapidly detecting Listeria monocytogenes serotype 4h by using two pairs of primers.Type: GrantFiled: May 27, 2020Date of Patent: November 28, 2023Assignee: Yangzhou UniversityInventors: Xin'an Jiao, Yuelan Yin, Youwei Feng, Hao Yao, Xinyu Sun, Zhiming Pan, Xiang Chen, Jing Wang
-
Patent number: 11821044Abstract: The present invention relates to methods for screening a subject for a cancer. In particular, the present invention relates to a method (A) for screening a subject for a cancer comprising the steps of i) extracting the cell free nucleic acids from a sample obtained from the subject, ii) determining the total concentration of mitochondrial cell free nucleic acids, ii) determining the total concentration of nuclear cell free nucleic acids iv) calculating the ratio of the level determined at step ii) to the concentration determined at step iii), v) comparing ratio determined at step iv) with a predetermined corresponding reference value and vi) concluding that the subject suffers from a cancer when the ratio determined at step iv) is lower than the predetermined corresponding reference value or concluding that the subject does not suffer from a cancer when the ratio determined at step iv) is higher than the predetermined corresponding reference value.Type: GrantFiled: June 23, 2020Date of Patent: November 21, 2023Assignees: INSTITUT NATIONAL DE LA SANTÈ ET DE LA RECHERCHE MÈDICALE, INSTITUT REGIONAL DU CANCER DE MONTPELLIER, UNIVERSITE DE MONTPELLIERInventors: Alain Thierry, Safia El Messaoudi
-
Patent number: 11821046Abstract: Disclosed are nucleic acid oligomers, including amplification oligomers, capture probes, and detection probes, for detection of Zika virus nucleic acid. Also disclosed are methods of specific nucleic acid amplification and detection using the disclosed oligomers, as well as corresponding reaction mixtures and kits.Type: GrantFiled: September 25, 2020Date of Patent: November 21, 2023Assignee: Gen-Probe IncorporatedInventors: Kui Gao, Jeffrey M. Linnen
-
Patent number: 11814682Abstract: A method is described for determining carrier status of an embryo for a balanced chromosomal rearrangement (BCR) prior to implantation of the embryo. The method involves obtaining cells from the embryo from at least day 4 post in vitro fertilization; conducting long-read nanopore sequencing of the DNA of the cells and the BCR carrier parent to detect at least one breakpoint; preparing primers specific to the breakpoint; employing the primers in a polymerase chain reaction customized to the breakpoint (cBP-PCR) to determine whether the breakpoint is indicative of BCR; and determining on the basis of cBP-PCR whether the embryo status is BCR carrier or BCR noncarrier; and conducting Sanger sequencing to determine balance in the embryo. The method can assist BCR carrier parents to pursue reproductive technologies while preventing vertical transmission of a BCR to offspring.Type: GrantFiled: October 29, 2020Date of Patent: November 14, 2023Assignee: REPROBIOGEN INC.Inventors: Svetlana Madjunkova, Clifford L. Librach
-
Patent number: 11808677Abstract: According to an aspect of the present disclosure, there is provided a polymerase chain reaction (PCR) patch which is provided as a gel type having a net-like structure forming micro-cavities, wherein at least a part of a plurality of reagents used in a PCR are contained in the micro-cavities, and when the patch contacts with an external region, the reagents contained in the micro-cavities move to at least a portion of the external region, and a PCR of a target DNA included in a sample located in the external region is performed.Type: GrantFiled: February 23, 2017Date of Patent: November 7, 2023Assignee: NOUL CO., LTD.Inventors: Dong Young Lee, Chan Yang Lim, Kyung Hwan Kim
-
Patent number: 11807901Abstract: Disclosed herein is a method of utilizing an enzyme in a nucleic acid manipulation process, the method comprising: a) transforming a microorganism with a non-native enzyme; b) inducing expression of the enzyme in the microorganism, thereby producing the non-native enzyme; c) adding the microorganism of step b) directly to a non-naturally occurring nucleic acid manipulation process, wherein the non-native enzyme is not purified from the microorganism prior to addition to the nucleic acid manipulation process; and carrying out the nucleic acid manipulation process using the enzyme. Importantly, this method can be carried out without the need to purify the enzyme from the cell producing it before it is used in the nucleic acid manipulation method. Also disclosed herein is a kit for carrying out a nucleic acid manipulation process, the kit comprising a) a microorganism expressing a non-native enzyme; b) nucleic acids of interest; and c) reagents for use in the nucleic acid manipulation process.Type: GrantFiled: November 15, 2018Date of Patent: November 7, 2023Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMInventors: Andrew Ellington, Sanchita Bhadra, Jared Ellefson, Jimmy Gollihar, Arti Pothukuchy, Michelle Byrom, Raghav Shroff
-
Patent number: 11802309Abstract: A heating mechanism for use in DNA applications such as DNA amplification, extraction and sterilization is provided. Nanoparticles having photo-thermal properties are put in contact with a reaction mixture and irradiated with an activation light beam to activate these photo-thermal properties, thereby releasing heat. Nanoparticles of several types may be used. Use of the same nanoparticles or of different one to monitor the reaction using a different light beam is also presented.Type: GrantFiled: February 13, 2020Date of Patent: October 31, 2023Assignee: THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING /MCGILL UNIVERSITYInventors: Philip Roche, Andrew Kirk, Lenore Beitel, Miltiadis Paliouras, Mark Trifiro, Vamsy Chodavarapu, Mohamed Najih, Joachim Thiemann
-
Patent number: 11795446Abstract: A carrier includes a supporting part on which a specific number of cells A are supported. The cells A contain a specific number of copies of a nucleic acid, and the supporting part is made of a water-decomposable material.Type: GrantFiled: March 16, 2021Date of Patent: October 24, 2023Assignee: Ricoh Company, Ltd.Inventors: Yuuki Yonekawa, Hirotaka Unno, Satoshi Nakazawa
-
Patent number: 11795494Abstract: In certain embodiments, the present invention provides amplification methods in which nucleotide tag(s) and, optionally, a barcode nucleotide sequence are added to target nucleotide sequences. In other embodiments, the present invention provides a microfluidic device that includes a plurality of first input lines and a plurality of second input lines. The microfluidic device also includes a plurality of sets of first chambers and a plurality of sets of second chambers. Each set of first chambers is in fluid communication with one of the plurality of first input lines. Each set of second chambers is in fluid communication with one of the plurality of second input lines. The microfluidic device further includes a plurality of first pump elements in fluid communication with a first portion of the plurality of second input lines and a plurality of second pump elements in fluid communication with a second portion of the plurality of second input lines.Type: GrantFiled: February 3, 2021Date of Patent: October 24, 2023Assignee: FLUIDIGM CORPORATIONInventors: Andrew May, Peilin Chen, Jun Wang, Fiona Kaper, Megan Anderson
-
Patent number: 11795505Abstract: Disclosed herein, inter alia, are degradable nanoparticles, nanoarrays, and methods of use thereof in nucleic acid sequencing.Type: GrantFiled: March 9, 2023Date of Patent: October 24, 2023Assignee: Singular Genomics Systems, Inc.Inventors: Mark Kalaj, Daan Witters
-
Patent number: 11773440Abstract: The identification of mutations that are present in a small fraction of DNA templates is essential for progress in several areas of biomedical research. Though massively parallel sequencing instruments are in principle well-suited to this task, the error rates in such instruments are generally too high to allow confident identification of rare variants. We here describe an approach that can substantially increase the sensitivity of massively parallel sequencing instruments for this purpose. One example of this approach, called “Safe-SeqS” for (Safe-Sequencing System) includes (i) assignment of a unique identifier (UID) to each template molecule; (ii) amplification of each uniquely tagged template molecule to create UID-families; and (iii) redundant sequencing of the amplification products. PCR fragments with the same UID are truly mutant (“super-mutants”) if ?95% of them contain the identical mutation.Type: GrantFiled: April 28, 2021Date of Patent: October 3, 2023Assignee: The Johns Hopkins UniversityInventors: Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos, Isaac A. Kinde
-
Patent number: 11773430Abstract: Methods and compositions for detecting the presence of a pathogen are described. In particular, this document provides a method of detecting a pathogen-associated nucleic acid in a biological sample of a subject, where the method comprises using one or more unimolecular aptamer-based sensors comprising an aptamer-fluorophore complex and an amplification step to detect the pathogen-associated nucleic acid. Methods specific for detecting the presence of malaria and other mosquito-borne virus infections are also provided.Type: GrantFiled: October 17, 2017Date of Patent: October 3, 2023Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITYInventors: Alexander Green, Duo Ma, Anli Tang
-
Patent number: 11773434Abstract: This invention relates to methods and compositions for assessing an amount of total cell-free DNA, such as from a transplant subject. The methods and composition provided herein can be used to determine risk of complications following transplantation, including infection, cardiac arrest, and death, in a subject.Type: GrantFiled: June 20, 2018Date of Patent: October 3, 2023Assignee: The Medical College of Wisconsin, Inc.Inventors: Aoy Tomita Mitchell, Michael Mitchell
-
Patent number: 11773436Abstract: Disclosed herein include systems, methods, compositions, and kits for labeling nucleic acid targets in a sample. In some embodiments, nucleic acid targets (e.g., mRNAs) are initially barcoded on the 3? end and are subsequently barcoded on the 5? end following a template switching reaction and intermolecular and/or intramolecular hybridization and extension. 5?- and/or 3?-barcoded nucleic acid targets can serve as templates for amplification reactions and/or random priming and extension reactions to generate a sequencing library. The method can comprise generating a full-length sequence of the nucleic acid target by aligning a plurality of sequencing reads. Immune repertoire profiling methods are also provided in some embodiments.Type: GrantFiled: November 6, 2020Date of Patent: October 3, 2023Assignee: Becton, Dickinson and CompanyInventors: Christina Chang, Margaret Nakamoto